Bioventix Plc

As of December 31, 2025, Bioventix Plc carries a market capitalization of 106.63M, placing it among publicly traded companies globally. Its enterprise value stands at 100.54M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bioventix Plc's next confirmed earnings release is scheduled for October 26, 2026.

As of December 31, 2025, Bioventix Plc has 5.22M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Bioventix Plc maintains a current ratio of 6.12, meaning it holds 6.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Bioventix Plc's stock has declined approximately 9.92% over the past 52 weeks. The 50-day moving average sits at 19.39, while the 200-day moving average is 18.92.

These figures are as of December 31, 2025. Total book value stands at 12.66M, with working capital of 11.70M providing operational flexibility.